Ringing in the new year with a new name, Canada’s Research-Based Pharmaceutical Companies (Rx&D) is changing its brand to become Innovative Medicines Canada to better reflect its values and mandate. “Our everyday work is reflected in our new brand, and we’re very excited to unveil this new name to Canadians,” said Russell Williams, president of Innovative Medicines … Read more
Canadians face wait times of over 460 days in order to get access to new, potentially lifesaving medicines in public drug plans, according to a new IMS Brogan report commissioned by Canada’s Research-Based Pharmaceutical Companies (Rx&D). The “2015 Access to New Medicines in Public Drug Plans: Canada and Comparable Countries” report finds Canada seriously lagging compared to other similar OECD countries … Read more
Following the Minister of Health’s announcement, Russell Williams, president, Canada’s Research-Based Pharmaceutical Companies (Rx&D), issued the following statement: “Rx&D and its members are supportive of the Government of Canada’s intention to make the reporting of drug shortages mandatory in Canada. I indicated to the Minister of Health our intention to endorse any efforts the government … Read more
Canada’s Research-Based Pharmaceutical Companies (Rx&D) and MEDEC – Canada’s Medical Technology Companies – welcome the Asia-Pacific Economic Cooperation (APEC) Leaders’ (Heads of State) endorsement of the Nanjing Declaration to Promote Ethical Business Environments in the Medical Device and Biopharmaceutical Sectors (2014-2020). “We welcome the APEC leader’s endorsement of strong and principled ethical business environments in the … Read more
On behalf of the Board of Directors of Canada’s Research-Based Pharmaceutical Companies (Rx&D), chair Mark Lievonen is pleased to announce that Mel Cappe has accepted the position of chair of the Board of Directors for Rx&D’s Health Research Foundation (HRF). Cappe’s accomplishments include serving as the president of the Institute for Research on Public Policy, … Read more
A new KPMG study shows that research and development investments made by Canada’s innovative pharmaceutical sector continue to be chronically under-reported by the Government of Canada at an increasing amount year-over-year. The “Summary of 2013 R&D Spending and Investments by Rx&D Members” is the fourth annual report commissioned by Canada’s Research-Based Pharmaceutical Companies (Rx&D) that shows … Read more
Rx&D, the association of Canada’s research-based pharmaceutical companies, announces the launch of Rx&D’s Canadian Innovation Timeline to mark the centennial anniversary of the organization and the members in Canada. The Canadian Innovation Timeline was developed in partnership with Let’s Talk Science to celebrate and promote the incredible contributions Canadian researchers have made to the discovery and … Read more
Canada’s Research-Based Pharmaceutical Companies (Rx&D) applauds the government’s announcement regarding the successful conclusion of negotiations surrounding the Comprehensive Economic and Trade Agreement (CETA). President of Rx&D Russell Williams said this is an essential step in strengthening Canada’s position on the international life sciences stage and a more level playing field in intellectual property protection can lead … Read more
Canada’s Research-Based Pharmaceutical Companies (Rx&D) and BioTalent Canada have signed a landmark agreement that will see the two organizations collaborate on identifying and developing the job skills required to address the skills gap for Canada’s knowledge-based life sciences and biotechnology industries. Canada’s bio-economy continues to be an important driver to sustain the country’s economic growth, … Read more
Three new reports released by Canada’s Research-Based Pharmaceutical Companies (Rx&D) provide a combined snapshot of the enormous impact the discovery and development of innovative new medicines play in the lives of people across the country. The reports—prepared independently by KPMG, RiskAnalytica and SECOR—were commissioned by Rx&D to get a firmer understanding of the health and … Read more
